TEAM
Atlassian Corporation
$214.75
+3.33% 2026-10-19
Technology
TEAMSPY
1W
+3.4%
1M
+11.8%
3M
+122.7%
6M
+200.4%
YTD
+32.4%
1Y
+41.3%
Grades vs sector
Momentumno data–
Momentum
no data
Percentile within its GICS sector across the S&P 1500.
Growthno data–
Growth
no data
Percentile within its GICS sector across the S&P 1500.
Valueno data–
Value
no data
Percentile within its GICS sector across the S&P 1500.
Profitabilityno data–
Profitability
no data
Percentile within its GICS sector across the S&P 1500.
Revisionsno data–
Revisions
no data
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
Our models
Not held by any of our 3 live models right now.
Momentum Top 15
not ranked (outside this model's universe or screens)
Quality Growthnot ranked (outside this model's universe or screens)
Momentum Blendnot in the current book
Key stats
Market cap$54.4B
P/E (trailing)–
P/E (forward)31.9
52-week range56.01 – 223.70
Revenue growth (YoY, latest qtr)+27.6%
Dividend yield0.00%
Analyst consensusBuy (31)
Mean price target$218.78 (+2%)
Valuation & fundamentals
Bottom line
Leans undervalued
Model read-out from the numbers below, not advice. Score +1 (DCF counts double).
•DCF (base case)above the price by 6%
▲Piotroski F-score7/9
▲Altman Z6.0 (safe)
▲Net debt / EBITDA-1.7x
•Analyst target+2% (31 analysts)
Discounted cash flow
Bear
$114
-47%
growth 15% · disc. 11.4% · term. 2.0%
Base
$228
+6%
growth 25% · disc. 10.4% · term. 2.5%
Bull
$393
+83%
growth 32% · disc. 9.4% · term. 3.0%
A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.
Reverse DCFfor context, not a signal
A normal DCF guesses future cash flows and works out a price. A reverse DCF runs it backwards: it starts from today's price and asks how fast free cash flow would have to grow to justify it. It tells you what the market is assuming, not whether the stock is cheap or expensive, and it is not a buy or sell signal. Glossary
Today's price assumes free cash flow grows about 18% a year for 10 years.
Implied
+18%/yr
FCF, last 3 yrs
+16%/yr
FCF, last 5 yrs
+12%/yr
Revenue, last 3 yrs
+23%/yr
Revenue, last 5 yrs
+26%/yr
Same inputs as the DCF above: trailing free cash flow 1.3B, 10.4% discount rate, 2.5% growth after year 10, net cash and today's share count. Actual growth rates are compound annual rates from SEC annual filings through FY2026; "n/a" means too little history or a negative starting year.
Edit assumptions · recalculates instantly
Your value per share–
Free cash flow = operating cash flow − capital spending, trailing 12 months (FY to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.23 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.
Multiples vs sector
Forward EPS $6.74 vs trailing $-0.21. Forward P/E uses analysts' next-12-month estimate.
Backlog (remaining performance obligations)
RPO
$4.8B
as of 2026-06-30
vs a year ago
+45%
YoY
× TTM revenue
0.73×
coverage
Contracted revenue not yet recognized, from SEC filings (XBRL tag RevenueRemainingPerformanceObligation).
Quality & financial health
Gross margin
84.8%
Operating margin
0.2%
FCF margin
20.1%
Net margin
-0.8%
Return on equity
-5.1%
Return on invested capital
0.8%
Net debt / EBITDA
-1.7×
Current ratio
0.8×
Interest cover
0.2×
Cash conversion (OCF/NI)
–
Piotroski F-score 7/9 · last two fiscal years
✗ Positive net income✓ Positive operating cash flow✓ Return on assets improved✓ Cash flow above net income✓ Long-term debt / assets fell✗ Current ratio improved✓ No share dilution✓ Gross margin improved✓ Asset turnover improved
Altman Z-score 6.0 (safe zone; above 3.0 = safe, below 1.8 = distress). Not meaningful for banks and insurers.
Analysts
Mean target
$219
+2%
Analysts
31
Buy
Range
$145–$480
low – high
● price · ◆ mean target
Annual history
| FY | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2026 | $6.6B | $-53.8M | $1.3B |
| 2025 | $5.2B | $-256.7M | $1.4B |
| 2024 | $4.4B | $-300.5M | $1.4B |
| 2023 | $3.5B | $-486.8M | $842.3M |
| 2022 | $2.8B | $-519.5M | $750.5M |
| 2021 | $2.1B | $-579.0M | $758.4M |
From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +23.0%.
Earnings
Next report: 2026-11-05 · during market · EPS est 1.06
EstimateActual (beat)Actual (miss)
| Report | EPS est | Actual | Surprise |
|---|---|---|---|
| 2026-08-06 | 1.50 | 1.87 | +24.5% |
| 2026-04-30 | 1.34 | 1.75 | +31.0% |
| 2026-02-05 | 1.14 | 1.22 | +6.6% |
| 2025-10-30 | 0.84 | 1.04 | +24.1% |
| 2025-08-07 | 0.86 | 0.98 | +14.0% |
| 2025-05-01 | 0.93 | 0.97 | +4.8% |
| 2025-01-30 | 0.76 | 0.96 | +27.1% |
| 2024-10-31 | 0.58 | 0.77 | +32.8% |
Quarterly revenue
| Quarter | Revenue | YoY |
|---|---|---|
| 2026-06-30 | $1.8B | +27.6% |
| 2026-03-31 | $1.8B | – |
| 2025-12-31 | $1.6B | – |
| 2025-09-30 | $1.4B | – |
| 2025-06-30 | $1.4B | – |
Analyst actions
Guggenheim
PT $280
2026-10-19 · main
Buy → BuyPT $280
Keybanc
PT $235
2026-10-19 · main
Overweight → OverweightPT $235
Mizuho
PT $235
2026-10-15 · main
Outperform → OutperformPT $235
Wells Fargo
PT $230
2026-10-14 · main
Overweight → OverweightPT $230
Barclays
PT $222
2026-10-13 · main
Overweight → OverweightPT $222
RBC Capital
PT $235
2026-10-12 · main
Outperform → OutperformPT $235
Insider trades
Liu Gene
$70.8K
Chief Accounting Officer · 2026-10-12
SELL$70.8K
Liu Gene
$178.4K
Chief Accounting Officer · 2026-08-28
SELL$178.4K
Chuong James
$18.2K
Chief Financial Officer · 2026-08-19
SELL$18.2K
Chuong James
$371.0K
Chief Financial Officer · 2026-08-19
SELL$371.0K
Chuong James
$46.4K
Chief Financial Officer · 2026-08-19
SELL$46.4K
Chuong James
$98.2K
Chief Financial Officer · 2026-08-19
SELL$98.2K
Chuong James
$355.7K
Chief Financial Officer · 2026-08-19
SELL$355.7K
Chuong James
$94.9K
Chief Financial Officer · 2026-08-19
SELL$94.9K
Chuong James
$56.9K
Chief Financial Officer · 2026-08-19
SELL$56.9K
Chuong James
$3.7K
Chief Financial Officer · 2026-08-19
SELL$3.7K
Chuong James
$32.2K
Chief Financial Officer · 2026-08-19
SELL$32.2K
Chuong James
$25.4K
Chief Financial Officer · 2026-08-19
SELL$25.4K
News
Atlassian Corporation (TEAM) Shares More Than Double in the Third Quarter
Insider Monkey · 19h ago
1 Cash-Producing Stock to Research Further and 2 That Underwhelm
StockStory · Oct 19
Why Did XOM, V, TEAM Stocks Hit 52-Week Highs Last Week?
Stocktwits · Oct 18
Atlassian (TEAM) Stock May Look Fully Priced Following Its AMP AI Launch
Simply Wall St. · Oct 17
Did AI Workflow Push Just Shift Atlassian's (TEAM) Investment Narrative?
Simply Wall St. · Oct 17
Snowflake, Atlassian, Bandwidth, Five9, and Palo Alto Networks Stocks Trade Down, What You Need To Know
StockStory · Oct 16
Stats refreshed 2026-10-19 19:01:39 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
coteau
Coteau Systematic StrategiesSystematic equity research and model portfolios.Coteau Systematic Strategies publishes research, model portfolios and tools. It does not manage money or offer investment advice. Model results are hypothetical. Data: Yahoo Finance (delayed), SEC EDGAR.